Home/Filings/4/0001358403-19-000051
4//SEC Filing

Woodard Jr Joseph Paul 4

Accession 0001358403-19-000051

CIK 0001358403other

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 4:09 PM ET

Size

5.5 KB

Accession

0001358403-19-000051

Insider Transaction Report

Form 4
Period: 2019-04-25
Woodard Jr Joseph Paul
SVP Clinical & Medical Affairs
Transactions
  • Award

    Stock Option (right to buy)

    2019-04-25+25,00025,000 total
    Exercise: $3.01Exp: 2029-04-24Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on April 25, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001773944

Filing Metadata

Form type
4
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 4:09 PM ET
Size
5.5 KB